Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Related Articles by Review for PubMed (Select 23254429)

1.

Lucidone suppresses hepatitis C virus replication by Nrf2-mediated heme oxygenase-1 induction.

Chen WC, Wang SY, Chiu CC, Tseng CK, Lin CK, Wang HC, Lee JC.

Antimicrob Agents Chemother. 2013 Mar;57(3):1180-91. doi: 10.1128/AAC.02053-12. Epub 2012 Dec 17.

2.

Hepatitis C virus resistance to protease inhibitors.

Halfon P, Locarnini S.

J Hepatol. 2011 Jul;55(1):192-206. doi: 10.1016/j.jhep.2011.01.011. Epub 2011 Feb 1. Review.

3.

New targets for antiviral therapy of chronic hepatitis C.

B├╝hler S, Bartenschlager R.

Liver Int. 2012 Feb;32 Suppl 1:9-16. doi: 10.1111/j.1478-3231.2011.02701.x. Review.

PMID:
22212566
4.

Discovery of hepatitis C virus NS5A inhibitors as a new class of anti-HCV therapy.

Lee C.

Arch Pharm Res. 2011 Sep;34(9):1403-7. doi: 10.1007/s12272-011-0921-6. Review.

PMID:
21975800
5.

New HCV therapies on the horizon.

Vermehren J, Sarrazin C.

Clin Microbiol Infect. 2011 Feb;17(2):122-34. doi: 10.1111/j.1469-0691.2010.03430.x. Review.

6.

Anti-HCV drugs in the pipeline.

Yang PL, Gao M, Lin K, Liu Q, Villareal VA.

Curr Opin Virol. 2011 Dec;1(6):607-16. doi: 10.1016/j.coviro.2011.10.019. Epub 2011 Nov 13. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk